Production (Stage)
Innate Pharma S.A.
IPHA
$2.08
-$0.09-4.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.17% | -7.94% | 1.36% | 2.55% | -5.78% |
| Total Receivables | -96.69% | -96.28% | -72.35% | -72.03% | 55.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -53.60% | -47.80% | -11.26% | -10.22% | 26.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -85.87% | -84.10% | -7.75% | -6.67% | 31.59% |
| Total Current Assets | -45.74% | -38.96% | -24.18% | -23.29% | 9.48% |
|
|
|||||
| Total Current Assets | -45.74% | -38.96% | -24.18% | -23.29% | 9.48% |
| Net Property, Plant & Equipment | -23.95% | -14.44% | -22.31% | -21.40% | -23.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -87.07% | -86.91% | -72.35% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.82% | -1.92% | 118.51% | 121.07% | -22.76% |
| Total Assets | -40.62% | -33.20% | -25.30% | -24.42% | -9.08% |
|
|
|||||
| Total Accounts Payable | -13.32% | -2.48% | -12.96% | -11.94% | -35.16% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -8.71% | 2.70% | 64.26% | 66.19% | 339.69% |
| Total Finance Division Other Current Liabilities | -30.83% | -22.18% | -10.24% | -9.19% | -10.49% |
| Total Other Current Liabilities | -30.83% | -22.18% | -10.24% | -9.19% | -10.49% |
| Total Current Liabilities | -22.06% | -12.31% | -0.40% | 0.77% | -0.83% |
|
|
|||||
| Total Current Liabilities | -22.06% | -12.31% | -0.40% | 0.77% | -0.83% |
| Long-Term Debt | -32.12% | -23.63% | -25.52% | -24.65% | -18.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -72.16% | -68.68% | -68.99% | -68.63% | -70.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -16.53% | -6.10% | -16.67% | -15.69% | -14.39% |
| Total Liabilities | -22.34% | -12.63% | -14.70% | -13.70% | -12.15% |
|
|
|||||
| Common Stock & APIC | -4.68% | 7.24% | -0.66% | 0.51% | 4.68% |
| Retained Earnings | -7.42% | -20.85% | -8.02% | -9.29% | -5.49% |
| Treasury Stock & Other | -94.88% | -94.25% | -67.19% | -66.81% | -37.50% |
| Total Common Equity | -84.06% | -82.06% | -51.16% | -50.58% | -0.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -84.06% | -82.06% | -51.16% | -50.58% | -0.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -84.06% | -82.06% | -51.16% | -50.58% | -0.87% |
|
|
|||||